UBS OCONNOR LLC - THERAVANCE INC ownership

THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 2 filers reported holding THERAVANCE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of THERAVANCE INC
ValueSharesWeighting
Q1 2015$8,781,000,000
-21.2%
10,307,000
-26.6%
0.19%
-3.1%
Q4 2014$11,141,000,000
+81.0%
14,050,000
+116.2%
0.19%
+83.0%
Q3 2014$6,155,000,0006,500,0000.11%
Other shareholders
THERAVANCE INC shareholders Q3 2023
NameSharesValueWeighting ↓
PIPER SANDLER & CO. 500,000$491,0000.40%
Walleye Capital LLC 19,788,000$19,514,0000.37%
WOLVERINE ASSET MANAGEMENT LLC 27,976,000$27,582,0000.30%
SSI INVESTMENT MANAGEMENT LLC 3,410,000$3,350,0000.22%
OAKTREE CAPITAL MANAGEMENT LP 14,002,000$13,808,0000.15%
Radcliffe Capital Management, L.P. 5,000,000$4,912,0000.12%
D. E. Shaw & Co., Inc. 11,336,000$11,220,0000.01%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 1,060,000$1,041,0000.01%
TORONTO DOMINION BANK 5,450,000$5,336,0000.01%
Russell Investments Group, Ltd. 2,621,000$2,601,0000.01%
View complete list of THERAVANCE INC shareholders